MedTrace Logo

Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment

NCT01261533 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2013-05-23

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility, primary safety and efficacy of foldable capsular vitreous body (FCVB) in the treatment of retinal detachment, based on the multi-center clinical trial.

Conditions

  • Retinal Detachment

Interventions

DEVICE

foldable capsular vitreous body(FCVB)

FCVB with silicone oil inside is tamponaded into the vitreous cavity

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • GuangZhou WeiShiBo Biotechnology Co., ltd

    lead INDUSTRY

Principal Investigators

  • Qianying Gao, MD,Ph.D · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-12-31
Completion
2014-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01261533 on ClinicalTrials.gov